Ling Zhang

Title: Ling Zhang: Innovator in Antibody Therapeutics

Introduction

Ling Zhang is a prominent inventor based in Shanghai, China, known for his contributions to the field of antibody therapeutics. With a focus on innovative solutions for treating diseases, Zhang has secured two patents that highlight his expertise and commitment to advancing medical science.

Latest Patents

Zhang's latest patents include the "Anti-B7H3 antibody-exatecan analog conjugate and medicinal use thereof." This invention discloses an anti-B7H3 antibody-exatecan analog conjugate, along with a preparation method and its anti-tumor medicinal applications. Another significant patent is for "Anti-Aβ antibodies and antigen-binding fragments thereof," which involves a murine, chimeric, or humanized anti-Abeta antibody with a specific CDR region. This patent also covers an antigen-binding fragment, a pharmaceutical composition, and its usage for treating diseases such as Alzheimer's disease caused by amyloid beta protein.

Career Highlights

Throughout his career, Ling Zhang has worked with notable companies, including Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His work in these organizations has contributed to the development of innovative therapeutic solutions.

Collaborations

Zhang has collaborated with esteemed colleagues, including Hua Ying and Weikang Tao, to further enhance his research and development efforts in the field of antibody therapeutics.

Conclusion

Ling Zhang's innovative work in antibody therapeutics, particularly in the development of treatments for cancer and Alzheimer's disease, showcases his significant contributions to medical science. His patents reflect a dedication to improving patient outcomes through advanced therapeutic solutions.